Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

hospital price transparency

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

Thumbnail

Neuroradiologists support bipartisan bill that would tap foreign physicians to relieve staffing shortages

The Healthcare Workforce Resilience Act would recapture 15,000 unused immigrant visas, previously authorized by Congress, for overseas medical doctors.

change healthcare cyberattack

Change Healthcare cyberattack: A recap and update in 10 quotes

“This is what happens when everything merges and you only have one option.”

Thumbnail

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine. 

Hospital system accused of inaction after ultrasound technologist allegedly assaults 6 women

Sacramento, California-based Sutter Health and tech Henry Nweke deny the allegations.

FDA announces new Class I recall of drainage systems after 26 injuries

According to the agency, using these devices “may cause serious injuries or death.”

Medicare money payment reimbursement dollar decline george washington

Feds seeking public comment on private equity healthcare spending sprees

A joint announcement from the DOJ, FTC and HHS asks for providers, patients or other industry experts to share their experiences with private equity transactions, including those not typically subject to antitrust review by law.